Skip to search formSkip to main contentSkip to account menu

AM 2389

Known as: AM-2389, AM2389 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Cannabinoid Antagonist Drug Discrimination in Nonhuman Primates
Despite a growing acceptance that withdrawal symptoms can emerge following discontinuation of cannabis products, especially in… 
2011
2011
AM2389, a high-affinity, in vivo potent CB1-receptor-selective cannabinergic ligand as evidenced by drug discrimination in rats and hypothermia testing in mice
The endocannabinoid signaling system (ECS) has been targeted for developing novel therapeutics since ECS dysfunction has been… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)